Last reviewed · How we verify
A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.
Details
| Lead sponsor | Nanjing Leads Biolabs Co.,Ltd |
|---|---|
| Phase | PHASE2 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 110 |
| Start date | Wed Apr 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue May 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Advanced Solid Tumour
Interventions
- LBL-024 for Injection
- Capecitabine tablets
- Tislelizumab Injection
- Oxaliplatin injection
Countries
China